ClinicalTrialsFinder

Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Clinical Trials in Cincinnati, Ohio

1 recruitingCincinnati, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 2

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Recurrent Lung Non-Small Cell CarcinomaAdvanced Lung Non-Small Cell CarcinomaStage IIIB Lung Non-Small Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI)46 enrolled344 locationsNCT03191149